Prot# CSTI571 0106: A Phase III Study of STI571 vs Interferon-alpha (IFN-a) Combined w/ Cytarabine (Ara-C) in Patients w/ Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/31/00 → 9/30/15

Funding

  • Novartis Pharmaceuticals Corporation (CSTI571 0106)